A lab technician inspects filled vials of investigational coronavirus disease treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, U.S. March 11, 2020.
Picture taken March 11, 2020.said Monday that results from a phase 3 trial showed its antiviral drug remdesivir helped patients with moderate Covid-19.
The trial compared patients on either a five-day or 10-day course of remdesivir plus standard of care versus standard of care alone. Patients on a five-day course were 65% more likely to have clinical improvement at day 11 versus standard of care, according to Gilead. The odds of improvement in clinical status with the 10-day treatment course of remdesivir versus standard of care were also favorable, but not statistically significant, the company said.
"We now have three randomized, controlled clinical trials demonstrating that remdesivir improved clinical outcomes by several different measures," Gilead's Chief Medical Officer Dr. Merdad Parsey said in a statement. "Today's results showed that when treating moderate disease, a 5-day course of remdesivir led to greater clinical improvement than standard of care, adding further evidence of remdesivir's benefit to previously released study results.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Gilead trades that made millions on COVID-19 drug news raise eyebrowsWell-timed trades in Gilead Sciences Inc's options ahead of good news on the biopharmaceutical company's COVID-19 drug treatment may draw regulatory scrutiny, experts said.
続きを読む »
China reports two new coronavirus cases for May 30China recorded two new confirmed cases of coronavirus on May 30, down from four the day before, data from the country's health authority showed on Sunday.
続きを読む »
‘The next patient could be me’: For a family of Filipino doctors, pandemic is personalWhile they toil to save the lives of coronavirus patients, physicians face private struggles, too.
続きを読む »
Russia Approves Flu Drug’s Use Against Covid-19Russia’s Ministry of Health on Saturday approved a flu drug for use in fighting coronavirus after officials said preliminary testing showed hospitalized patients who took the pills recovered more quickly.
続きを読む »
See the 3D Models Hanifa Used to Launch Its Latest Collection on Instagram LiveDesigner Anifa Mvuemba planned the groundbreaking digital show before the coronavirus pandemic made it essential.
続きを読む »